Financhill
Back

Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings

Ionis Pharmaceuticals Price Quote

$33.95
-1.45 (-4.1%)
(Updated: November 21, 2024 at 5:55 PM ET)

Ionis Pharmaceuticals Key Stats

Sell
34
Ionis Pharmaceuticals (IONS) is a Sell

Day range:
$33.53 - $35.60
52-week range:
$33.63 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.13
P/B ratio:
8.04%

Volume:
2.2M
Avg. volume:
1.3M
1-year change:
-28.73%
Market cap:
$5.3B
Revenue:
$787.6M
EPS:
$-2.44

How Much Does Ionis Pharmaceuticals Make?

Is Ionis Pharmaceuticals Growing As A Company?

  • What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ionis Pharmaceuticals Stock Price Performance

What Is Ionis Pharmaceuticals 52-Week High & Low?

Ionis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ionis Pharmaceuticals?

Is Ionis Pharmaceuticals Cash Flow Positive?

  • What Is IONS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$351.9M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $562.9M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$229M

Ionis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    IONS return on invested capital is -21.57%
  • What Is Ionis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -12.41%
  • What Is IONS Return On Equity?
    ROE is a measure of profitability and is -93.21%

Ionis Pharmaceuticals Earnings Date & Stock Price

Ionis Pharmaceuticals Competitors

Ionis Pharmaceuticals Dividend Yield

Ionis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 26.14%
Revenue: -7.21% 3.14%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 61.44
Upside from Last Price: 73.55%

Major Shareholders

  • How many IONS shares are owned by institutional investors?
    284.5M IONS shares are owned by institutional investors
  • How many IONS shares are owned by insiders?
    1.4M IONS shares are owned by insiders